Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

Aarif Y. Khakoo, Shibani Pati, Stasia A. Anderson, William Reid, Mohamed F. Elshal, Ilsa I. Rovira, Ahn T. Nguyen, Daniela Malide, Christian A. Combs, Gentzon Hall, Jianhu Zhang, Mark Raffeld, Terry B. Rogers, William Stetler-Stevenson, Joseph A. Frank, Marvin Reitz, Toren Finkel

Research output: Contribution to journalArticle

Abstract

Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell-cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.

Original languageEnglish (US)
Pages (from-to)1235-1247
Number of pages13
JournalJournal of Experimental Medicine
Volume203
Issue number5
DOIs
StatePublished - May 15 2006
Externally publishedYes

Fingerprint

Kaposi's Sarcoma
Mesenchymal Stromal Cells
Neoplasms
Stem Cells
Stromal Cells
Aptitude
Human Development
Cadherins
Neutralizing Antibodies
Tumor Cell Line
Growth and Development
Antineoplastic Agents
Protein Kinases
Carcinogenesis
Growth
Population

ASJC Scopus subject areas

  • Immunology

Cite this

Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., ... Finkel, T. (2006). Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. Journal of Experimental Medicine, 203(5), 1235-1247. https://doi.org/10.1084/jem.20051921

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. / Khakoo, Aarif Y.; Pati, Shibani; Anderson, Stasia A.; Reid, William; Elshal, Mohamed F.; Rovira, Ilsa I.; Nguyen, Ahn T.; Malide, Daniela; Combs, Christian A.; Hall, Gentzon; Zhang, Jianhu; Raffeld, Mark; Rogers, Terry B.; Stetler-Stevenson, William; Frank, Joseph A.; Reitz, Marvin; Finkel, Toren.

In: Journal of Experimental Medicine, Vol. 203, No. 5, 15.05.2006, p. 1235-1247.

Research output: Contribution to journalArticle

Khakoo, AY, Pati, S, Anderson, SA, Reid, W, Elshal, MF, Rovira, II, Nguyen, AT, Malide, D, Combs, CA, Hall, G, Zhang, J, Raffeld, M, Rogers, TB, Stetler-Stevenson, W, Frank, JA, Reitz, M & Finkel, T 2006, 'Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma', Journal of Experimental Medicine, vol. 203, no. 5, pp. 1235-1247. https://doi.org/10.1084/jem.20051921
Khakoo, Aarif Y. ; Pati, Shibani ; Anderson, Stasia A. ; Reid, William ; Elshal, Mohamed F. ; Rovira, Ilsa I. ; Nguyen, Ahn T. ; Malide, Daniela ; Combs, Christian A. ; Hall, Gentzon ; Zhang, Jianhu ; Raffeld, Mark ; Rogers, Terry B. ; Stetler-Stevenson, William ; Frank, Joseph A. ; Reitz, Marvin ; Finkel, Toren. / Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. In: Journal of Experimental Medicine. 2006 ; Vol. 203, No. 5. pp. 1235-1247.
@article{ac6d15a85f60489db91e16573f467ac9,
title = "Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma",
abstract = "Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell-cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.",
author = "Khakoo, {Aarif Y.} and Shibani Pati and Anderson, {Stasia A.} and William Reid and Elshal, {Mohamed F.} and Rovira, {Ilsa I.} and Nguyen, {Ahn T.} and Daniela Malide and Combs, {Christian A.} and Gentzon Hall and Jianhu Zhang and Mark Raffeld and Rogers, {Terry B.} and William Stetler-Stevenson and Frank, {Joseph A.} and Marvin Reitz and Toren Finkel",
year = "2006",
month = "5",
day = "15",
doi = "10.1084/jem.20051921",
language = "English (US)",
volume = "203",
pages = "1235--1247",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "5",

}

TY - JOUR

T1 - Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

AU - Khakoo, Aarif Y.

AU - Pati, Shibani

AU - Anderson, Stasia A.

AU - Reid, William

AU - Elshal, Mohamed F.

AU - Rovira, Ilsa I.

AU - Nguyen, Ahn T.

AU - Malide, Daniela

AU - Combs, Christian A.

AU - Hall, Gentzon

AU - Zhang, Jianhu

AU - Raffeld, Mark

AU - Rogers, Terry B.

AU - Stetler-Stevenson, William

AU - Frank, Joseph A.

AU - Reitz, Marvin

AU - Finkel, Toren

PY - 2006/5/15

Y1 - 2006/5/15

N2 - Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell-cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.

AB - Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell-cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.

UR - http://www.scopus.com/inward/record.url?scp=33646690027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646690027&partnerID=8YFLogxK

U2 - 10.1084/jem.20051921

DO - 10.1084/jem.20051921

M3 - Article

C2 - 16636132

AN - SCOPUS:33646690027

VL - 203

SP - 1235

EP - 1247

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 5

ER -